Physician

Adam L Griggs, D.O.

According to 2025 Medicare claims, Adam Griggs, D.O. (NPI: 1043275647) practices pulmonary disease in the Orlando-Kissimmee-Sanford, FL market, with the plurality of this provider's patient population coming from Osceola, FL. This provider's primary affiliated billing organization is PULMONARY DISEASE SPECIALISTS, PA (NPI: 1649484809; TIN: 59-2545833) and primary practice location at 34741-2344.

Griggs' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 647 traditional Medicare patients, billed 1,730 HCPCS/CPT codes, and received $118,693 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,708 prescription claims across 601 beneficiaries totaling $1,935,327 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 3,335 claims. Open Payments data shows 74 records totaling $1,504. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $228,167 to $118,693. In contrast, Part D prescription costs have moved sharply higher in recent years, from $459,088 to $1,935,327. For DME billing, reported payments moved sharply higher in recent years, from $80,090 to $559,695.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	821	2,475	$228,167
2016	747	2,560	$215,360
2017	707	1,949	$165,637
2018	584	1,760	$160,488
2019	606	2,003	$175,207
2020	512	1,697	$147,564
2021	536	2,049	$172,031
2022	514	1,871	$138,765
2023	535	1,864	$134,907
2024	647	1,730	$118,693

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	203	958	$459,088
2016	191	851	$512,873
2017	173	851	$362,877
2018	212	1,020	$401,749
2019	197	944	$419,214
2020	209	870	$591,618
2021	218	880	$979,486
2022	227	1,000	$1,032,027
2023	388	1,458	$1,248,532
2024	601	2,708	$1,935,327

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	565	1,658	$84,314
2016	540	1,604	$74,365
2017	587	1,598	$61,249
2018	602	1,659	$80,826
2019	630	1,766	$84,624
2020	657	1,916	$84,734
2021	658	2,006	$184,886
2022	654	2,150	$439,091
2023	693	2,189	$488,382
2024	1,120	3,335	$570,127

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	231	318	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	141	162	$58
94726	Test to determine lung volumes using sensors	112	114	$37
94729	Test to examine how well the lungs exchange gases	112	114	$37
94060	Test to measure expiratory airflow and volume changes before and after medication administration	121	123	$25

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	446	21,144	$438,026
Ofev	Nintedanib Esylate	21	630	$273,574
Xolair	Omalizumab	52	1,456	$163,950
Aralast Np	Alpha-1-Proteinase Inhibitor	13	364	$140,420
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	82	3,720	$76,699

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	44	367	$372,574
E0483	High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each	Y	N/R	53	$49,471
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	57	438	$32,447
A7031	Face mask interface, replacement for full face mask, each	N	60	135	$12,438
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	16	$12,220

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	74	$1,504	Takeda Pharmaceuticals U.S.A., Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam L. Griggs, D.O.?

Tedicare shows public-source Medicare data for Adam L. Griggs, D.O. (NPI 1043275647), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam L. Griggs, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam L. Griggs, D.O.?

Adam L. Griggs, D.O. is linked to PULMONARY DISEASE SPECIALISTS, PA (billing NPI 1649484809) in the available physician profile data.

Does Adam L. Griggs, D.O. have Open Payments data?

Adam L. Griggs, D.O. has 74 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.